6Case Reporting and Epidemiological Assessment
39ANTHRAX
7Prevention
40Brucellosis
8Protective Equipment
41Glanders & Meliodosis
9First Aid
42Plague
10Protective Measures and Handling of Casualties
43Q Fever
11Patient Decontamination
44Tularemia
12Infection Control
45Botulinum Toxins
13Medical Evacuation
46Ricin Toxin
14Aeromedical Isolation Team
47Staphylococcus Enterotoxins
15BACTERIAL AGENTS
48Encephalitis Viruses
16ANTHRAX
49Hemorrhagic Fever Viruses
17BRUCELLOSIS
50Smallpox
18GLANDERS AND MELIOIDOSIS
51Appendix E: Medical Sample Collection for Biological Threat Agents
19PLAGUE
52Bacteria and Rickettsia
20Q FEVER
53Bacteria and Rickettsia
21TULAREMIA
54Toxins
22VIRAL AGENTS
55Viruses
23SMALLPOX
56Appendix F: Specimens for Laboratory Diagnosis
24VENEZUELAN EQUINE ENCEPHALITIS (VEE)
57Appendix G: BW Agent Lab Identification
25VIRAL HEMORRHAGIC FEVER
58Appendix H: Differential Diagnosis of Chemical
26BIOLOGICAL TOXINS
59Appendix I: Comparative Lethality of Selected Toxins & Chemical Agents in Laboratory Mice
27BOTULINUM
60Appendix J: Aerosol Toxicity in LD50 vs. Quantity of Toxin
28RICIN
61Appendix K: Investigational New Drugs (IND)
29STAPHYLOCOCCAL ENTEROTOXIN B
62Appendix L: Use of Drugs / Vaccines in Special or Vulnerable Populations in the Context of Bioterrorism.
30T-2 MYCOTOXINS
63Appendix M: Emergency Response Contacts FBI & Public Health
31Emerging Threats and Future Biological Weapons
64Federal Bureau of Investigation (FBI) Field Offices (listed by city)
32DETECTION
65State and Territorial Public Health Directors (listed by state)
33PERSONAL PROTECTION
